MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Potent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-xL

Author(s)
Ryan, Jeremy; Letai, Anthony; Dutta, Sanjib; Chen, T. Scott; Kougentakis, Christos; Keating, Amy E.; ... Show more Show less
Thumbnail
DownloadKeating_Potent and specific.pdf (2.433Mb)
PUBLISHER_CC

Publisher with Creative Commons License

Creative Commons Attribution

Terms of use
Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/
Metadata
Show full item record
Abstract
The Bcl-2 family of proteins plays a critical role regulating apoptosis, and pro-survival Bcl-2 family members are important therapeutic targets due to their overexpression in different cancers. Pro-apoptotic Bcl-2 homology 3 (BH3)-only proteins antagonize pro-survival Bcl-2 protein functions by binding directly to them, and a sub-class of BH3-only proteins termed sensitizers can initiate apoptosis via this mechanism in response to diverse signals. The five pro-survival proteins Bcl-x[subscript L], Mcl-1, Bcl-2, Bcl-w and Bfl-1 differ in their binding preferences, with Bcl-x[subscript L], Bcl-2 and Bcl-w sharing similar interaction profiles for many natural sensitizers and small molecules. Peptides that bind selectively to just one or a subset of family members have shown utility in assays that diagnose apoptotic blockades in cancer cells and as reagents for dissecting apoptotic mechanism. Combining computational design, combinatorial library screening and rational mutagenesis, we designed a series of BH3 sensitizer peptides that bind Bcl-x[subscript L] with sub-nanomolar affinity and selectivity up to 1000-fold over each of the four competing pro-survival proteins. We demonstrate the efficacy of our designed BH3 peptides in assays that differentiate between cancer cells that are dependent on different pro-survival proteins.
Date issued
2017-06-16
URI
http://hdl.handle.net/1721.1/109994
Department
Massachusetts Institute of Technology. Department of Biology
Journal
Journal of Molecular Biology
Publisher
Elsevier
Citation
Dutta, Sanjib, Jeremy Ryan, T. Scott Chen, Christos Kougentakis, Anthony Letai, and Amy E. Keating. “Potent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-xL.” Journal of Molecular Biology 427, no. 6 (March 2015): 1241–1253. © 2014 Elsevier Ltd.
Version: Author's final manuscript
ISSN
0022-2836
1089-8638

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.